US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
Select product by product line
Infectious diseases
Infectious diseases
Simplifying access to advanced diagnostic testing for the prevention, treatment and care of infectious diseases.
Diasorin’s complete range of exclusive and specialty assays are designed for critical and high impact infectious disease testing. They thus ensure fast, accurate detection and screening for laboratories of any size. This is why for decades, clinicians around the world have put their trust in the high quality of our diagnostic results to support treatment decisions and clinical follow-up of infected patients.
Select panel
Select product name
LIAISON® BRAHMS MR-proADMTM
The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADMTM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.
LIAISON® BRAHMS PCT® II Gen
LIAISON® BRAHMS PCT® II Gen is a CLIA assay for the quantitative determination of procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis for critically ill patients regarding the progression of relevant bacterial infections.
LIAISON® MeMed BV®
The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON® MeMed BV® ideal for patients with suspected acute infections.